Month: March 2019

Activist investor Starboard Value has ended its fight against Bristol-Myers Squibb’s buyout of biotechnology company Celgene after two prominent proxy advisors announced their support for the deal earlier on Friday. The withdrawal comes hours after both Institutional Shareholder Services and Glass Lewis recommended Bristol-Myers shareholders vote in favor of its bid. “Despite the substantial swell
0 Comments
Check out the companies making headlines midday Friday: Celgene — Shares of Celgene rose 6.58 percent after proxy advisors Institutional Shareholder Services and Glass Lewis recommended that Bristol-Myers Squibb shareholders vote in favor of its bid to buy Celgene. The recommendations come weeks before shareholders vote on the $74 billion buyout of the biotechnology company.
0 Comments
South Church Zuiderkerk and old Houses over canal with boats with tulips, Amsterdam, Netherlands Getty Amsterdam had three large real estate bubbles from 1582 to 1810. The real estate market was entirely different 200-400 years ago but those Amsterdam bubbles shared at least two similarities with modern real estate bubbles. Changes in the amount of
0 Comments
Listed for $5.2 million, Nantucket Lightship was converted into a luxury yacht residence with a bright red hull and custom wood interiors. Courtesy of William and Kristen Golden Who wouldn’t want to live on Nantucket? It’s uniquely blessed with galvanizing ocean waves, phenomenal whale watching and mesmerizing sunsets. Nantucket Lightship has served the USA well
0 Comments
An interview with billionaire CEO of Citadel, Kenneth Griffin. In this interview, Kenneth discusses trading and investing at his Hedge Fund, Citadel, including how he first got interested in trading and the evolution of Citadel. Kenneth also talks about his early life, real estate and philanthropy. Like if you enjoyed Subscribe for more:http://bit.ly/InvestorsArchive Follow us
0 Comments